# JHS Svendgaard Laboratories (NSE: JHS) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/JHS · Pivot · prices to 30 Sep 2026

JHS Svendgaard Laboratories (NSE: JHS) closed at ₹12.45 on 30 Sep 2026. With a market capitalisation of ₹109 Cr, it ranks 2613th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the FMCG sector; its industry is Household & Personal Products.

Its return on equity was 0.1% in FY25. Over the past year the share price has risen 14.1%. Its 52-week range is ₹6.26 (30 Mar 2026) to ₹13.90 (27 Oct 2025); the last close is 10.4% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹33 Cr (+29.9% year on year) and net profit −₹4 Cr, on a consolidated basis. Promoters held 33.85% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹12.45 |
| Market cap | ₹109 Cr |
| ROE | 0.1% (FY25) |
| ROCE | 0.1% (FY25) |
| Debt to equity | 0.07 |
| 52-week high | ₹13.90 (27 Oct 2025) |
| 52-week low | ₹6.26 (30 Mar 2026) |
| 1-year return | +14.1% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹33 Cr | +29.9% | −₹4 Cr | — | −₹0.42 |
| Q3 FY26 | ₹23 Cr | +2.7% | ₹1 Cr | — | ₹0.09 |
| Q2 FY26 | ₹22 Cr | +13.2% | −₹0 Cr | — | −₹0.02 |
| Q1 FY26 | ₹23 Cr | −4.2% | ₹1 Cr | — | ₹0.12 |
| Q4 FY25 | ₹25 Cr | +16.2% | −₹7 Cr | — | −₹0.84 |
| Q3 FY25 | ₹23 Cr | +58.5% | −₹2 Cr | −18,500.0% | −₹0.21 |
| Q2 FY25 | ₹20 Cr | +4.0% | −₹10 Cr | — | −₹1.24 |
| Q1 FY25 | ₹24 Cr | +28.6% | −₹1 Cr | — | −₹0.08 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹0 Cr | ₹0 Cr |
| FY24 | ₹0 Cr | ₹0 Cr |
| FY23 | ₹0 Cr | ₹0 Cr |
| FY22 | ₹0 Cr | ₹0 Cr |
| FY21 | ₹0 Cr | ₹0 Cr |
| FY20 | ₹0 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 33.85%
- Foreign institutions: 3.14%
- Non-institutions: 63.01%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Vishwaraj Sugar Industries](https://app.pivotnow.in/stock/VISHWARAJ) | ₹5.08 | ₹111 Cr | — | — |
| [Thrive Future](https://app.pivotnow.in/stock/THRIVE) | — | ₹109 Cr | — | — |
| [Dhampure Specia](https://app.pivotnow.in/stock/DHAMPURE) | — | ₹108 Cr | — | — |
| [Arunjyoti Bio](https://app.pivotnow.in/stock/ABVL) | — | ₹107 Cr | — | — |
| [Mayank Cattle](https://app.pivotnow.in/stock/MCFL) | — | ₹106 Cr | — | — |
| [Puretrop Fruits](https://app.pivotnow.in/stock/PURETROP) | — | ₹105 Cr | — | — |

## Questions and answers

### What is the share price of JHS Svendgaard Laboratories today?

JHS Svendgaard Laboratories (NSE: JHS) last closed at ₹12.45 on 30 Sep 2026. Its 52-week high is ₹13.90 and its 52-week low is ₹6.26.

### What is the market cap of JHS Svendgaard Laboratories?

JHS Svendgaard Laboratories' market capitalisation is ₹109 Cr (₹109 Cr) at the 22 Oct 2026 close, ranking 2613th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of JHS Svendgaard Laboratories?

Return on equity was 0.1% in FY25 and return on capital employed was 0.1% in FY25 (standalone figures).

### Is JHS Svendgaard Laboratories a debt-free company?

No. JHS Svendgaard Laboratories' debt-to-equity ratio was 0.07 in FY25, with total debt of ₹0 Cr.

### What were JHS Svendgaard Laboratories' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), JHS Svendgaard Laboratories reported revenue of ₹33 Cr, +29.9% year on year, and net profit of −₹4 Cr.

### How has JHS Svendgaard Laboratories stock performed over the last year?

JHS Svendgaard Laboratories' share price has risen 14.1% over the past year, +62.8% over three months and +54.5% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of JHS Svendgaard Laboratories?

As of 30 Jun 2026: promoters 33.85%, foreign institutions 3.14%, non-institutions 63.01%.

### Who are JHS Svendgaard Laboratories' competitors?

The listed FMCG companies closest to JHS Svendgaard Laboratories by market cap are Vishwaraj Sugar Industries, Thrive Future, Dhampure Specia, Arunjyoti Bio, Mayank Cattle and Puretrop Fruits.

### Is JHS Svendgaard Laboratories a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out JHS Svendgaard Laboratories' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on JHS against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.